Development and validation of a Level A in-vitro in-vivo correlation for tofacitinib modified-release tablets using extrudable core system osmotic delivery technology
Open Access
- 1 April 2020
- journal article
- research article
- Published by Elsevier in European Journal of Pharmaceutical Sciences
- Vol. 147, 105200
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Extended‐Release Once‐Daily Formulation of Tofacitinib: Evaluation of Pharmacokinetics Compared With Immediate‐Release Tofacitinib and Impact of FoodThe Journal of Clinical Pharmacology, 2016
- Comparison of Deconvolution-Based and Absorption Modeling IVIVC for Extended Release Formulations of a BCS III Drug Development CandidateThe AAPS Journal, 2015
- Applications of In Vitro–In Vivo Correlations in Generic Drug Development: Case StudiesThe AAPS Journal, 2015
- A Commentary on Scale‐Up of Pan Coating Process Using Microenvironmental ControlJournal of Pharmaceutical Sciences, 2014
- In Vitro- In Vivo Correlation’s Dissolution Limits SettingPharmaceutical Research, 2014
- Analysis of level A in vitro–in vivo correlations for an extended‐release formulation with limited bioavailabilityBiopharmaceutics & Drug Disposition, 2012
- Oral osmotically driven systems: 30 years of development and clinical useEuropean Journal of Pharmaceutics and Biopharmaceutics, 2009
- Extrudable core system: Development of a single-layer osmotic controlled-release tabletJournal of Controlled Release, 2009
- Intestinal fluid volumes and transit of dosage forms as assessed by magnetic resonance imagingAlimentary Pharmacology & Therapeutics, 2005
- A Thermodynamic Model for Organic and Aqueous Tablet Film CoatingPharmaceutical Development and Technology, 2005